Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
Background One major limitation for broader applicability of allogeneic hematopoietic cell transplantation (allo-HCT) in the past was the lack of HLA-matched histocompatible donors. Preclinical mouse studies using T-cell depleted haploidentical grafts led to an increased interest in the use of ex vi...
Saved in:
| Main Authors: | Razan Mohty, Zaid Al Kadhimi, Mohamed Kharfan-Dabaja |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Hematology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2024.2326384 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Haploidentical Stem Cell Transplantation With Dual Source of Cells and Post‐Transplant Cyclophosphamide
by: Ana Marcela Rojas Fonseca‐Hial, et al.
Published: (2025-02-01) -
Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation
by: Kyung Taek Hong, et al.
Published: (2025-03-01) -
Current status of conditioning regimens in haploidentical hematopoietic cell transplantation
by: Junichi Sugita, et al.
Published: (2024-12-01) -
Optimizing Haploidentical Hematopoietic Stem Cell Transplantation: Enhancing Outcomes in Hematologic Malignancies in Resource-Limited Settings
by: Owattanapanich W, et al.
Published: (2025-03-01) -
Immune Reconstitution after Haploidentical Hematopoietic Stem Cell Transplantation with Different Non‐T‐Cell Depletion Protocols
by: Xiao‐Di Ma, et al.
Published: (2025-06-01)